NCT00296348View on ClinicalTrials.gov

Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation

PHASE3CompletedINTERVENTIONAL

Enrollment

198

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Kidney Transplantation

Interventions

DRUG

tacrolimus

immunosuppression

DRUG

mycophenolate mofetil

oral

DRUG

daclizumab

oral

DRUG

steroids

oral

Trial Locations (35)

1020

Brussels

1082

Budapest

3000

Leuven

10126

Torino

13353

Berlin

16132

Genova

16147

Genova

20122

Milan

30625

Hanover

35128

Padua

44093

Nantes

49100

Petah Tikva

50924

Cologne

69120

Heidelberg

69437

Lyon

75935

Paris

400006

Cluj-Napoca

150 06

Prague

00165

Rome

04-730

Warsaw

Unknown

Cape Town

Johannesburg

Taipei

Ankara

Izmir

413 45

Gothenburg

B4 6NH

Birmingham

BS2 8BJ

Bristol

G3 8SJ

Glasgow

LS9 7TF

Leeds

L12 2AP

Liverpool

WC1 3JH

London

M27 4HA

Manchester

NE1 4LP

Newcastle upon Tyne

NG5 1PB

Nottingham

Sponsors

Lead Sponsor

Astellas Pharma Inc

All Listed Sponsors

lead

Astellas Pharma Inc

INDUSTRY

NCT00296348 - Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation | Biotech Hunter | Biotech Hunter